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Time for new guidelines in advanced healthcare:
the mission of The EPMA Journal to promote an





Changing long-held beliefs is never easy. As a consequence of the accumulating clinical data and knowledge
about the epidemiology and pathological mechanisms of the most frequent causes of morbidity and mortality, we
are currently reconsidering our view of the origins and progression of cardiovascular, oncologic and
neurodegenerative diseases. Optimistic versus pessimistic prognosis for healthcare sector depends much on
diagnostic, preventive and treatment approaches, which healthcare systems will preferably adopt in the near
future. PPPM offers great promise for the future practice of medicine. We are pleased to announce this first open
access volume of The EPMA Journal following its transfer to BioMed Central two years after publication of the first
article in the journal.
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Why predictive, preventive and personalized
medicine?
Predictive, preventive and personalized medicine
(PPPM) offers great promise for the future practice of
medicine. Essential components of this approach include
well-organized population screening protocols utilizing
novel diagnostic biomarkers of disease states, targeted
prevention of common human pathologies, optimal
treatment planning and personalized medicine thereby
resulting in a substantial improvement in the quality of
life. This approach also offers the advantage of deliver-
ing care at potentially reduced costs to the population
at large, thereby addressing social and ethical issues
related to access to and affordability of healthcare. A
broad distribution and a routine clinical utilization of
advanced technological approaches could enable a sig-
nificant portion of the population to reach and exceed
100 years of age yet remaining vibrant and in excellent
physical and mental health as actively contributing
members of society. One of the central issues discussed
is the screening for predisposition of healthy individuals
to potential pathologies later in life. The groups at risk
identified within the general population can be given a
fair chance of a focused diagnosis with multidisciplinary
expertise and well-timed preventive measures. The relia-
bility of the blood-tests proposed, potential application
to clinical routines, enormous economic and social
impacts of the new generation of molecular- and nano-
technology-based diagnostic approaches - are all dis-
cussed in The EPMA Journal.
Changing long-held beliefs is never easy
As a consequence of the accumulating clinical data and
knowledge about the epidemiology and pathological
mechanisms of the most frequent causes of morbidity
and mortality, we are currently reconsidering our view
of the origins and progression of cardiovascular, oncolo-
gic and neurodegenerative diseases. The majority of
these pathologies are of chronic nature: they progress
from precursor lesions over one or even several decades
of life until a diagnosis is made that is often too late for
effective therapeutic intervention. An excellent example
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nessed in the European Union. In most industrialized
countries and countries with large populations, the per-
manently growing cohort of people with diabetes creates
a serious healthcare problem and dramatic health eco-
nomic burden. Estimates for diabetes prevalence in the
years 2030 is half a billion patients worldwide [Figure 1].
Furthermore, the contemporary onset of the dominant
type 2 diabetes has already been observed in subpopula-
tions of teenagers [2]. Severe complications secondary to
early onset of diabetes mellitus, such as retinopathy,
nephropathy, silent ischemia, dementia, and cancer,
could lead to collapsing healthcare systems.
Our message is that new guidelines should create the
robust juristic and economic platform for advanced
medical services utilizing the cost-effective models of
risk assessment followed by tailored treatments focused
on the precursor stages of chronic disease [3]. The
EPMA Journal provides highly professional multidisci-
plinary insights into current “disease care” versus desir-
able “healthcare” mechanisms to promote the paradigm
change from delayed interventional “disease care” to
PPPM as the medicine of the future [4].
Innovation by integrative view: PPPM as the
“three-dimensional” vision in medical approaches
Optimistic versus pessimistic prognosis in future devel-
opments of the healthcare sector depends much on
diagnostic, preventive and treatment approaches which
healthcare will hopefully adopt in the near future [5].
Without innovation in healthcare, chronic disorders can
cause such a dramatic level of burden that any perfor-
mance of personalized medicine will not be feasible
from an economic point of view. In contrast, effective
utilization of advanced early/predictive diagnostics and
targeted prevention could enable rapidly aging popula-
tions in Europe and elsewhere to be economically effec-
tive to society. Therefore, it is timely to consider the
integrative medical approaches to advance healthcare
utilizing the innovation by functional links within
PPPM, such as predictive diagnostics as the basis for
concomitant targeted prevention, patient profiling as the
basis for individualized treatment algorithms and medi-
cal approaches tailored to the patient. In this context,
The EPMA Journal promotes this “three-dimensional”
vision in medical approaches, namely as outlined in
[Figure 2].
Figure 1 Worldwide prevalence of diabetes mellitus with a more pessimistic prognosis for the next 3 decades: current literature
updates [1].
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acceptance in The EPMA Journal
There are some features of a paper design specific for
the articles published with The EPMA Journal that are
highly appreciated by readers, namely:
￿ Highly informative content that provides an over-
view of corresponding topics, including related
multi- and inter-disciplinary aspects in a reader-
friendly manner that makes articles particularly use-
ful for professionals working in allied medical fields
and non-medical braches.
￿ A reasonable combination of at least two aspects of
the PPPM-concept; such as: predictive diagnostics fol-
lowed by treatment design tailored to the patient; or
innovative approach for population screening combined
with concomitant recommendations for targeted pre-
vention and individually created treatment algorithms.
￿ Discussion of the status quo (currents achieve-
ments & problems) overview followed by outlook for
future trends and prognosis of developments
￿ A clear message in each publication supplied with
a well-formulated PPPM-related title, a correspond-
ingly structured abstract and conclusions including
expert recommendations in the field
￿ Smart paper-design characterized by reader-
friendly subheadings of paragraphs for ease of
navigation
￿ A good balance between clinical aspects and tech-
nological solutions, status quo and perspectives, text
and illustrative materials
￿ Overall excellent scientific and technological level of
publications that undergo an additional evaluation by
the Editorial Board (more than 50 experts from more
than 30 countries worldwide) for consideration in
“The EPMA Journal Award“ for distinguished articles
presented at the regular EPMA world congresses.
Educational value of The EPMA Journal
The EPMA Journal is for everyone: on reading the jour-
nal, readers can learn a new philosophy in medicine,
novel trends in healthcare and biomedical education.
The journal provides important information for indivi-
duals of various professional and scientific backgrounds.
Professionals can consider the general concept of multi-
disciplinary approaches and learn the mindset of related
medical areas and other scientific branches. A partial list
of those who will especially benefit from the information
provided in the journal is as follows:
￿ professionals in conventional and molecular diag-
nostics, biomedicine, biotechnologies, ethics and
economics, and the healthcare industry
￿ universities, research units, private and public
hospitals
￿ patients and their family members
￿ international associations with healthcare-oriented
scientific, research and public health-related activ-
ities/responsibilities
￿ political organizations and authorities active in the
healthcare sector
To reach the maximum educational impact, the
review articles in The EPMA Journal are created
according to the principle of the informational pyramid
turned upside-down: highly specific topics that indivi-
dual professional groups work on (the pyramid-tip) are
brought into more generalized scientific context and,
further, correlated with concrete tasks to be performed
in the healthcare sector. Consequently, PPPM-related
aspects potentially interesting for corresponding border
areas and giving an overview of other scientific
branches. An example is provided in [Figure 3]. The
authors are requested to provide the outlook and
expert recommendations for further developments in
the branch.
The mission of the European Coordinator in this field
of PPPM is performed by the European Association for
Predictive, Preventive and Personalized Medicine. The
concepts of innovative European and international pro-
jects, which EPMA represents for further consideration
at the EU Commission, the European Parliament, NIH/
Figure 2 “Three dimensional” vision in medical approaches.
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world-leading professionals (not restricted to Europe).
The EPMA Mission and Objectives in the field of pre-
dictive, preventive and personalized medicine have been
introduced to UNO [Figure 4]. The participants of the
meeting agreed that the paradigm change from curative to
PPPM can only be achieved by coordinated measures
focused on solving the accumulating problems in health-
care and the concomitant economic burden that societies
across the globe are facing more and more. This is a new
philosophy in healthcare and the platform for personalized
patient’s treatment considered as the medicine of future.
Practical application of innovative technologies in
favour of predictive diagnostics, targeted preventive
measures and personalized patient treatment in Eur-
opean healthcare and in global scale is the central idea
of the Association. Through The EPMA Journal,t h e
Association creates a professional forum to discuss most
Figure 3 The structure of informational pyramid characteristic for review articles in The EPMA Journal: an example is provided for
diabetes research relevant for healthcare application under participation of several related areas.
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dictive, preventive and personalized medicine.
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Figure 4 EPMA goes global in consensus with United Nations:
first meeting of the EPMA-Representatives with the Vice-
Secretary General of UNO took place in Geneva on December
8th 2009. From left to right: EPMA President - Vincenzo Costigliola,
UNO Vice-Secretary General - Sergej Ordzhonikidze, EPMA Secretary
General - Olga Golubnitschaja [2].
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